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Abstract: The link between liver dysfunction and decreased mitochondrial oxidative phosphorylation
in sepsis has been clearly established in experimental models. Energy transduction is plastic: the
efficiency of mitochondrial coupling collapses in the early stage of sepsis but is expected to increase
during the recovery phases of sepsis. Among the mechanisms regulating the coupling efficiency of
hepatic mitochondria, the slipping reactions at the cytochrome oxidase and ATP synthase seem to be
a determining element, whereas other regulatory mechanisms such as those involving proton leakage
across the mitochondrial membrane have not yet been formally proven in the context of sepsis. If the
dysfunction of hepatic mitochondria is related to impaired cytochrome c oxidase and ATP synthase
functions, we need to consider therapeutic avenues to restore their activities for recovery from sepsis.
In this review, we discussed previous findings regarding the regulatory mechanism involved in
changes in the oxidative phosphorylation of liver mitochondria in sepsis, and propose therapeutic
avenues to improve the functions of cytochrome c oxidase and ATP synthase in sepsis.
Citation: Eyenga, P.; Rey, B.; Eyenga,
L.; Sheu, S.-S. Regulation of
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1. Introduction
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Sepsis and septic shock remain a main cause of death in intensive care units despite
numerous therapeutic trials [1]. Sepsis-related mortality frequently results from multi-organ
failure, characterized by impaired pulmonary function, liver failure, cardiac dysfunction,
acute renal failure and disseminated intravascular coagulation [2].
Liver failure associated with sepsis is often considered a late-stage feature of critical
illness, manifesting as jaundice and hyperbilirubinemia [3]. However, recent experimental
studies have revealed that liver dysfunction is an early event in sepsis [4,5]. Early depression of hepatocellular function is characterized by the decreased capacity of the liver
mitochondria to supply adenosine triphosphate (ATP) [6]. This is associated with a higher
rate of reactive oxygen species generation by liver mitochondria [6], the accumulation of
oxidative damage and the clearing of dysfunctional mitochondria (i.e., mitophagy) [7].
Although these early processes lead to downregulation of hepatocellular function, they
do not appear to result in cell death or irreversible structural damage [8]. It has been
suggested that this initial loss of function and decrease in aerobic respiration may be a
protective adaptative response that prevents cell death, allowing function to return over
time [9]. It has therefore been predicted that late recovery of liver function is associated with
increased efficiency of mitochondrial oxidative phosphorylation [10] and/or activation of
mitochondria biogenesis [11].
In a previous study, we tested this hypothesis by examining the time course of the
functional properties of liver mitochondria in a rodent model of severe sepsis [12]. Contrary
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to expectations, we found that restoration of efficient mitochondrial oxidative phosphorylation did not occur 36 h after the onset of sepsis, despite the induction of mitochondrial
biogenesis mechanisms [12]. From a mechanistic point of view, the lack of an improvement
in mitochondrial function seems to be related to a marked decrease in the content of cytochrome c oxidase and ATP synthase and their impact on oxidative phosphorylation. The
aim of this article was to describe the changes in oxidative phosphorylation efficiency that
occur in liver mitochondria during sepsis, to explore the different regulatory mechanisms
involved and to clarify the role of cytochrome c oxidase in this context. We also discuss
some therapeutic avenues that could improve the functions of cytochrome c oxidase and
ATP synthase and restore mitochondrial oxidative phosphorylation efficiency in patients
with sepsis.
2. Mitochondrial Oxidative Phosphorylation
2.1. Mitochondrial Structure
Mitochondria are double-membrane intra-cytoplasmic organelles found in most eukaryotic cells, with the exception of mammalian erythrocytes. The outer membrane enclosing the organelle forms a semi-permeable barrier separating the mitochondria from the
cytosol. The outer mitochondrial membrane is freely permeable to small molecules and
contains special channels capable of transporting large molecules. The inner membrane
delimits two operating volumes: the matrix and the intermembrane space between the
inner and outer membrane (Figure 1). The inner membrane has many cristae containing
the protein components of the electron transport chain (ETC), which is composed of transmembrane protein complexes (Complexes I to IV) and the freely mobile electron transfer
carriers ubiquinone and cytochrome c. The ETC complex is organized as a super-complex
specifically configured to function properly [13]. These assembled components, together
with F1F0-ATP synthase (Complex V), form the basis of ATP production during oxidative
phosphorylation (Figure 1). Oxidative phosphorylation is defined as the phosphorylation
of adenosine diphosphate (ADP) to ATP using energy stored as a proton electrochemical
gradient derived from the ETC’s activity. During this process, the ETC uses the oxidation
of reducing equivalents from metabolic substrates to transfer protons across the inner mitochondrial membrane via three proton pumping enzyme complexes (NADH: ubiquinone
oxidoreductase (I), cytochrome c reductase (III) and cytochrome c oxidase (IV)). The accumulation of protons in the intermembrane space creates an electrochemical gradient known
as a proton motive force, which is used by the ATP synthase to catalyze the endergonic
synthesis of ATP from ADP and inorganic phosphate. ATP generated in the mitochondrial
matrix is then exported to the cytoplasm by the adenine nucleotide translocator (ANT) to
fulfill the cytoplasmic energy demand.
2.2. Oxidative Phosphorylation Efficiency
Mitochondrial oxidative phosphorylation is a major source of hepatocellular ATP
production under aerobic conditions. The energy demand of the cell is difficult to quantify
during sepsis. Nevertheless, the ability of mitochondria to sense and respond to changes in
nutrient availability and energy demand is critical for the maintenance of hepatocellular
homeostasis. Within the mitochondria, the coupling between the rate of oxidation and the
rate of ATP generation (phosphorylation) is flexible and can be regulated [14]. In a state
of homeostasis, the efficiency of oxidative phosphorylation is set such that the coupling
between substrate oxidation (mitochondrial respiration) and ATP production can meet
the cellular demand for ATP. Conversely, when the stimulation of substrate oxidation
(mitochondrial oxygen consumption) does not lead to an increase in ATP generation in stoichiometric proportion, this expresses an uncoupling of the oxidation and phosphorylation
reactions. Therefore, studying the oxidative phosphorylation efficiency of liver mitochondria isolated from septic animals provides information on the ability of mitochondria to
meet hepatocellular ATP demand.
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level of energy demand: the maximum State 3 phosphorylation rate (State 3), which is far
from the physiological state. Another approach is to directly quantify mitochondrial ATP
production, either by using a magnesium probe that binds to ATP and ADP [15] or by measuring ATP production spectrophotometrically [6,12,16,17] in a system using hexokinase
(HK) and glucose-6-phosphate dehydrogenase (G6-PDH) to convert ATP to nicotinamide
adenine dinucleotide phosphate (NADPH) (Figure 2A). No assumption about the amount
of ATP produced is required in this approach, as ATP production is quantified based on the
linear relationship with NADPH absorbance. Furthermore, since hexokinase hydrolyzes
ATP as it leaves the mitochondria, the ADP and ATP concentrations remain stable (i.e.,
“clamped”) throughout the experimental period [18], allowing quantification of oxidative
phosphorylation under steady-state rates. In the context of sepsis, quantification of the
efficiency of liver mitochondria using ADP:O methods yielded conflicting results, although
the authors used a peritonitis model of sepsis such as cecal ligation and puncture (CLP)
that mimicked human sepsis [19–21]. Using this gold standard model of experimental
sepsis [22], Herminghaus et al. [19] showed a time-dependent decrease in ADP:O (i.e., 96 h
after the induction of peritonitis), while other authors showed an increase in the oxygen
consumption of isolated liver mitochondrial [20] and no change in ADP:O [21]. These results [20,21] were surprising, given that the oxygen consumption of hepatocytes was found
to be lowered during sepsis [20] and that a depletion of hepatocellular ATP had previously
been observed [23] using the same experimental model. Moreover, several years later,
Brealey and collaborators confirmed, in a clinical study, the depletion of ATP in the muscles
of a septic patients and linked this depletion to the poor outcome [24]. The question of
when the ATP depletion occurs during sepsis and the mechanisms involved thus remained
to be explored. Clearly, a rebound increase in oxygen consumption and ATP production in
the recovery phase of sepsis would reflect mitochondrial recovery. In recent studies with
a rodent model of peritonitis, we used the second approach to study the time course of
oxidative phosphorylation in liver mitochondria during sepsis [6,12]. This protocol allows
the measurement of ATP generation and oxygen consumption while maintaining constant
low concentrations of ADP in the respiratory medium to create phosphorylating conditions
close to those of intact cells where the oxidative phosphorylation state is between States 4
and 3 [25]. The ATP:O ratio can be read, even in the presence of some intrinsic uncoupling,
from the slope of the linear relationship between phosphorylation and the respiratory rate
(Figure 2C) [26]. Using this approach, we established a time course of liver mitochondrial
function by measuring the effective ATP production related to oxygen consumption of
mitochondria isolated from the livers of septic rats at different time points during the development of sepsis (i.e., 6, 24 and 36 h). In these studies [6,12], we showed that sepsis leads to
a change in ATP turnover in liver mitochondria, with the linear relationship between ATP
production and respiration shifting to the right, indicating some degree of uncoupling between ATP generation and oxygen consumption by the mitochondria [12]. Such a decrease
in energy efficiency (uncoupling of oxidative phosphorylation) reflects an alteration of the
processes involved in the regulation of mitochondrial oxidative phosphorylation caused by
sepsis. Three main non-exclusive mechanisms may be involved, either (1) at the level of
membrane conductance (proton and or cation leakage), (2) at the coupling site between
the electron and proton fluxes through the respiratory chain, or (3) at the level of coupling
between the proton and ATP synthesis fluxes through mitochondrial ATP synthase [14].
Note that there are other mechanisms for regulating mitochondrial ATP synthesis, such
as depletion of the substrate for oxidative phosphorylation [27,28] or the dissipation of
mitochondrial membrane potential through the mitochondrial permeability transition pore
(mPTP), which have already been extensively reviewed [29,30]. Nevertheless, we focused
on the three main mechanisms of regulation of oxidative phosphorylation efficiency mentioned above and deciphered those that are relevant in the context of sepsis as summarized
in Figure 3.
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Figure 2. Assay chemistry and instrumentation. (A) The ATP:O ratio represents the ratio of ATP
efficiency of the oxidative phosphorylation. This ratio is determined using the “hexokinase system”
synthesis based on oxygen consumption measured simultaneously. It allows us to measure the efbased on the regeneration of ADP [17,25], thus making it possible to obtain a stable State 3. The
ficiency of the oxidative phosphorylation. This ratio is determined using the “hexokinase system”
intensity of State 3 can be modulated by increasing concentrations of ADP, resulting in the kinetics of
based on the regeneration of ADP [17,25], thus making it possible to obtain a stable State 3. The
ATP synthesis being obtained as a function of the consumption of oxygen between State 4 (the absence
intensity of State 3 can be modulated by increasing concentrations of ADP, resulting in the kinetics
of ATP synthesis) and State 3 (maximum ATP synthesis). The reaction catalyzed by hexokinase (HK)
of ATP synthesis being obtained as a function of the consumption of oxygen between State 4 (the
is as follows: synthesized ATP is measured indirectly by evaluating glucose-6-phosphate production
absence of ATP synthesis) and State 3 (maximum ATP synthesis). The reaction catalyzed by hexoduring the reaction. Glucose-6-phosphate dehydrogenase (G6PDH) allows the formation of NADPH
kinase (HK) is as follows: synthesized ATP is measured indirectly by evaluating glucose-6-phosfrom glucose-6-phosphate: HK glucose + ATP gGlucose-6-phosphate + ADP. The quantity of NADPH
phate
production during the reaction. Glucose-6-phosphate dehydrogenase (G6PDH) allows the
formed during
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at a wavelength of 340 nm
formation
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from can
glucose-6-phosphate:
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and is directly proportional to the amount of ATP synthesized. (B) Typical trace of mitochondrial
respiration. The respiration rate (determined by the slope of the curve) is calculated by the amount
of consumed oxygen/minute/mg of protein. The State 2 non-phosphorylating state is respiration
in the absence of ATP synthesis. State 3 is respiration in the presence of ATP synthesis. State 4 is
the respiration in the presence of oligomycin, an ATP synthase inhibitor. Cytochrome c oxidase
activity is the maximal respiration with ascorbate and N,N,N0 N0 -tetra methyl-p-phenylenediamine
(TMPD) as a substrate. (C) ATP:O is the linear relationship between ATP production and oxygen
consumption measured with the addition of different amounts of exogenous ADP. The mitochondrial
ATP synthesis is initiated by the addition of different amounts of ADP. The intensity of State 3 can
be modulated by increasing the concentration of ADP, resulting in the kinetics of ATP synthesis
being obtained as a function of oxygen consumption between State 4 (absence of ATP synthesis) and
State 3 (maximum ATP synthesis). There is a linear relationship between ATP synthesis and oxygen
consumption when the oxidative phosphorylation rate increases by the addition of higher amounts
of ADP.
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mitochondria energized with NADH or FADH2 exhibit a basal oxygen consumption level
even if no ADP is provided in the respiratory medium (Figure 2B). This mitochondrial
respiration in the absence of ATP synthesis (non-phosphorylating State 2) compensates
for the loss of protons through the inner mitochondrial membrane. The addition of ADP
and Pi stimulates ATP synthesis (phosphorylating State 3) through the return of protons
through ATP synthase, decreasing the proton motive force and thus stimulating respiration.
Inhibitors such as oligomycin, which blocks the proton channel of ATP synthase, thus
inhibit the respiration related to phosphorylation processes (non-phosphorylating State 4).
The oligomycin-insensitive respiration is partly explained by a passive return of protons
to the matrix across the inner mitochondrial membrane and provides information on the
membrane’s conductance to protons. This process of membrane leakage constitutes a
shortfall in ATP synthesis through a decrease in the proton motive force. Although an
increase in non-phosphorylating State 4 respiration in hepatic mitochondria is observed
during sepsis [12,32], it does not appear to be related to an increase in proton leakage, as
explained below. In studies of proton leakage in vitro from isolated liver mitochondria,
proton leakage-associated respiration could be measured as a function of the membrane
potential (∆ΨM ) and provided information on membrane conductance to proton [33].
Figure 1 (insert) shows a typical graph of the kinetic response of membrane proton leakage
(oligomycin-insensitive respiration) to membrane potential in isolated liver mitochondria.
Whereas Ohm’s law would predict that the intensity of proton leakage through the inner
membrane should increase linearly as the membrane’s potential increases, the relationship
between proton leakage and membrane potential is not linear at high membrane potential
values. In other words, the proton leakage does not depend linearly on its driving force, indicating that proton conductance increases greatly at high potentials [34]. We concomitantly
studied mitochondrial proton leakage and oxidative phosphorylation efficiency [6,12] in
hepatic mitochondria and found that the non-ohmic part of the curve in septic rats was
very similar to that of the controls, although the mitochondrial oxidative phosphorylation
efficiency showed uncoupling at 36 h after CLP [12]. These results suggest that the decrease
in the efficiency of mitochondrial oxidative phosphorylation observed at the later stages of
sepsis (i.e., 36 h after CLP) is not driven by increased membrane conductance to protons.
Although it has been shown that protons can return to the matrix through movement at the
lipid–membrane protein interface, it has been proposed that under “basal” conditions, only
a small percentage of basal leakage is mediated by the lipid bilayer and that the presence of
membrane proteins is necessary to increase membrane conductance to protons [35]. During
sepsis, a decrease in the mitochondrial cardiolipin concentration would reflect a decrease
in the mitochondrial mass rather than disorganization of the inner membrane, which is
contrary to the hypothesis of proton leaks at the lipid–membrane protein interface [36].
Taken together, these observations suggest that the involvement of transporters, such as
adenine nucleotide transporter (ANT) [37], and/or uncoupling proteins (UCPs) [14] appear
to be decisive in the dissipation of the mitochondrial proton gradient during sepsis. The
increased expression and activity of these proteins could therefore explain the increase
in non-phosphorylating State 4 respiration observed during sepsis [38]. In this regard,
UCP2 has been proposed as a potential oxidative stress-induced uncoupling protein in
liver mitochondria during endotoxemia [39]. We have recently shown that upregulation
of UCP2 mRNA synthesis is accompanied by a decrease in ROS generation in the liver
mitochondria of septic rats [12] but does not affect proton leakage. Similar results on proton
leak were described by Yu et al. after endotoxemia in mice [40]. Even if UCP2 is capable
of transporting protons [41], our previous study showed that UCP2 activation in the liver
during sepsis is devolved to ROS dissipation [12,42] but has no measurable impact on
mitochondrial proton leakage [12,40]. However, this effect appears to be transient and
is unlikely to explain the uncoupling of oxidative phosphorylation efficiency observed
with unchanged proton leakage. With regard to ANT, which may also participate in the
dissipation of the proton gradient, it has been shown that the amount of this protein is
depleted during sepsis [43]. In this context, it is highly unlikely that ANT contributes to
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the increased leakage of protons and the associated decrease in the proton gradient during
late sepsis. We expected that mechanisms other than changes in conductance to protons
could be involved in the uncoupling of mitochondrial oxidative phosphorylation described
in the late period of sepsis.
B. Changes in Proton Pumping Stoichiometry
Originally described by Pietrobon et al. [44], alteration of the proton pumps expresses
a change in the amount of protons stored in the intermembrane space (redox slipping) or
the amount of protons returning to the matrix via ATP synthase (proton slipping), for the
same amount of oxidized electrons.
B.1 Redox Slipping
Redox slipping (intrinsic changes) of the ETC involves all compounds or mechanisms
leading to a decrease in the intrinsic efficiency of proton pumps. The “redox slipping”
or “slippage” of proton pumps within the respiratory chain results in reduced proton
pumping for the same number of electrons transferred along the respiratory chain [14].
This reduced efficiency can be balanced by increased respiration to maintain ATP synthesis.
This may occur at all three proton pumping sites (Complexes I, III and IV) in response
to the interaction of their thiol groups with nitric oxide metabolites [45] and may be favored by the large nitric oxide (NO) release [46] and the high level of NO metabolites
observed during sepsis [47]. Studies of the activities of liver mitochondrial complexes
in sepsis have shown the unchanged activity of Complex III [47,48], persistent inhibition
of Complex IV [47,48] and variable impairment of Complex I [47,48]. Zapelini et al. [48]
found no inhibition of Complex I, while Brealey et al. [47] showed a correlation between
Complex I inhibition and the severity of sepsis [47]. The discrepancies in the results on
the activities of ETC complexes during sepsis led us to measure mitochondrial ATP:O first
with specific substrates of Complex I and then with specific substrates of Complex II. Our
studies [6,12] showed that the uncoupling of mitochondrial oxidative phosphorylation
occurred at 36 h after CLP in rats, irrespective of the substrate used, and confirmed that
consistent and early inhibition of Complex IV occurs during sepsis. This observation led us
to conclude that only a change in the H+/e- stoichiometry of Complex IV (cytochrome c
oxidase) during sepsis appears to have physiological significance in altering the efficiency
of mitochondrial oxidative phosphorylation, as observed in other liver diseases [49,50].
Cytochrome c oxidase pumps protons from the matrix to the intermembrane space with two
different purposes and through two distinct pathways [51]: (i) the reduction of dioxygen
by 4 electrons to form 2 water molecules, where the H+/e– stoichiometry is fixed by the
chemical reactions and cannot vary; (ii) the constitution of the proton motive force, where
the H+/e– stoichiometry of the pumped protons may vary depending on the available
energy of the redox reactions and how the electrons and the proton flux are coupled. It has
been proposed that structural modifications at the surface of cytochrome c oxidase [52] or a
decrease in its content [12,53,54] or downregulation of mRNA expression of the key components [53,55] could result in electron transfer without proton pumping and thus decrease
the overall ATP:O [12,52]. A decrease in cytochrome c oxidase subunit 1 content is observed
in several organs during sepsis [12,53,54] and has been linked to downregulation of mRNA
synthesis [53,55] and/or protein depletion [56] following its oxidation and nitration [57,58].
NO, which is released in large quantities in the liver during sepsis [46], may have different
effects on mitochondrial ATP:O. Short-term incubation of liver mitochondria with NO
improves the ATP:O [59]; however, long-term incubation of NO with mitochondrial proteins lead to the formation of peroxynitrite, and inhibition of mitochondrial respiration
and ATP synthesis [60]. In addition to the direct interactions of NO metabolites with
cytochrome c oxidase that could decrease ATP generation, it has been proposed that cell
signaling mechanisms contribute to changes in cytochrome c oxidase’s stoichiometry and
ATP generation during sepsis [56]. In this regard, Huttemann et al. [56,61] have shown
that the phosphorylation of cytochrome c oxidase triggered by TNFα activation leads to
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a decrease in ATP generation in sepsis. TNFα is known to be a determining mediator
of early sepsis [27,46]. The kinetics of TNFα’s appearance in the liver vary considerably
between the experimental models of sepsis used and have led to mixed conclusions [56]
regarding the role of cell signaling as a mechanism of regulating oxidative phosphorylation.
Instead, we suggest that a global (multifactorial) degradation of mitochondrial proteins
and decrease in their activities occurs during sepsis (Figure 3B). As noted by Tavakoli [32],
a delay in mitochondrial protein resynthesis may be observed despite the activation of biogenesis [11,12] (Figure 3C). This delay in overall mitochondrial protein resynthesis during
sepsis could explained by mitochondrial oxidative phosphorylation uncoupling related to
slippage at the cytochrome c oxidase level [32]. This hypothesis is also supported by clinical
observations of overall mitochondrial protein degradation in the muscles of septic patients,
which contributes to the high incidence of muscle weakness in patients recovering from
severe sepsis [62]. In contrast to sepsis, other hepatic pathologies that are accompanied
by a decrease in cytochrome content paradoxically show an increase in ATP:O [50]. All of
these observations confirm that, through variations in the H+/e- stoichiometry, cytochrome
c oxidase appears to be a major site of adjustment of oxidative phosphorylation at the level
of the respiratory chain, provided that ATP synthase is fully functional, which does not
seem to be the case during sepsis, as we shall see below.
B.2 Proton Slipping
This uncoupled proton leakage mechanism occurs at the level of ATP synthase and
result in a decrease in the amount of ATP synthesized for a given proton flux. Such an
increase in H+/ATP stoichiometry has been demonstrated in vitro [63]. In ATP synthase,
the rotational mechanism is not always strictly coupled to proton flux, particularly when
nucleotide concentrations are low, or when ATP synthase subunits are depleted [12,64]. In
a previous study [12], we showed that ATP:O was unchanged 6 h after CLP and that this
was associated with maintenance of the β-subunit content of ATP synthase. Conversely,
36 h after CLP, a severe decrease in the β-subunit of ATP synthase was associated with an
uncoupling of oxidase phosphorylation. With regard to the parallel evolution of the ATP
synthase β-subunit pool and mitochondrial ATP:O, it appears that in sepsis, a decrease in
ATP synthase content leads to ATP production below its maximum [12,64,65]. It should be
noted that depletion of ATP synthase content may also decrease the ATP/ADP ratio, which,
in turn, should stimulate cytochrome c oxidase and increase ATP production [66]. However,
this mechanism is unlikely to occur during sepsis, as our studies [6,12] have shown that the
decline in ATP generation does not result in stimulation of cytochrome c oxidase activity.
Moreover, it has been shown that a decrease in the ATP subunit content could affect the
dimerization/oligomerization of ATP synthase and the formation of invaginations in the
inner mitochondrial membrane, which ultimately become mitochondrial cristae [67], with
a direct effect on ATP generation [68]. For instance, depletion of the β-subunit could lead
to a loss of mitochondrial cristae and super-complex assembly [69,70] and an increase in
the H+/ATP ratio without affecting the membrane potential (∆ΨM ) [51]. Further studies
are needed to establish the extent to which this mechanism plays a role in modulating the
efficiency of liver mitochondria during sepsis.
3. Therapeutic Implications
Potential therapeutic strategies targeting the mitochondria, including treatment with
antioxidants, ROS scavengers and membrane stabilizers (e.g., cyclosporine A, melatonin),
have already been extensively reviewed [71–73]. However, very few studies have focused
specifically on cytochrome c oxidase, which is a major point of the adjustment of mitochondrial function in sepsis. Nevertheless, Deutschman’s group has shown the beneficial
effect of exogenous cytochrome c supplementation [74,75], and glutamine [76] and caffeine [77] infusions on cytochrome c oxidase activity and cardiac function in septic mice.
Whether such supplementation can improve the efficiency of oxidative phosphorylation
and contribute to organ recovery from sepsis [9,10] remains to be explored. Moreover, the
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authors did not quantify the content of the cytochrome c oxidase subunit, so it cannot be
excluded that the increase in oxygen consumption reflected increased oxygen reduction,
but without efficient proton pumping [52]. Two recent studies have examined the effect
of common symptomatic treatments for sepsis on the function of cytochrome c oxidase
in the liver [78] and diaphragm in a rodent model of sepsis [79]. Yang et al. [78] have
shown that fluid resuscitation improves the function of cytochrome c oxidase; however,
the mechanism remains unclear. Recently, we have shown, in an experimental model of
sepsis, that early initiation of mechanical ventilation restores mitochondrial function in the
diaphragm. In this study, not only did mechanical ventilation preserve the cytochrome c
oxidase content and activity in the diaphragms of septic rats, but it also maintained the efficiency of oxidative phosphorylation (ATP:O) and lowered mitochondrial ROS production
by Complex III [79]. In addition to these simple resuscitation measures, interfering with
the inflammatory system [80] or cell signaling pathways [56] could improve the function of
cytochrome c oxidase. For example, a synthetic cortisol homolog, dexamethasone, has been
shown to restore the function of cytochrome c oxidase and prevent kidney injury 24 h after
cecal ligation and puncture in mice [80] and to increase the levels of F1Fo ATP synthase
and adenine nucleotide translocator (ANT) subunits [81]. However, administration of corticosteroids did not reduce 28-day mortality but increased metabolic disorders in sepsis [82].
The non-receptor tyrosine kinase Src and protein kinase Cε (PKCε) have been identified
as positive regulators of cytochrome c oxidase. Treatment with PKC activators, namely
diacylglycerol or 4β-phorbol 12-myristate 13-acetate (4β-PMA), resulted in increased cytochrome c oxidase activity in neonatal rat cardiomyocytes [83]. As far as we are aware,
these treatments are not yet used to treat sepsis. Other treatments to improve mitochondrial
ETC functioning have been proposed. Among them, parenteral injection of succinate could
improve ATP concentration in the liver after LPS injection in rats [84] and reduce mitochondrial ROS generation in the kidney after CLP in rats [85]. Although the above mentioned
therapeutics may improve mitochondrial ETC function in sepsis, an approach involving
the rapid synthesis of respiratory chain proteins deserves consideration. In this regard,
sirtuin-3 (SirT3) an NAD+ -dependent nuclear histone deacetylase [86], and songorine, an
active C20 -diterpene alkaloid from the lateral roots of Aconitum carmichaelii [87], have
been shown to induce mitochondrial biogenesis and restore cardiac function in an LPS
model of septic myocardiopathy. These molecules represent new therapeutic hopes for
countering the pathological effects of sepsis, to be tested in clinical trials.
4. Conclusions
The concept of coupling efficiency is essential to explain mitochondrial and liver dysfunction during sepsis and understanding it is necessary for the establishment of new forms
of therapy. Depletion and downregulation of cytochrome c oxidase and ATP synthase
appear to be consistent and are predominant mechanisms in the occurrence of uncoupling
of liver oxidative phosphorylation during sepsis. The mechanism of cytochrome c oxidase
depletion could involve phosphorylation of its subunit 1 [61] at an early stage of sepsis
through early pro-inflammatory mediators (i.e., TNF α) in addition to its early interaction
with NO [45], which leads to a lack of ROS regulation at its level [79], and consequently to
oxidation and depletion of mitochondrial proteins, including ATP synthase [12] (Figure 3B).
The decrease in cytochrome c oxidase and ATP synthase subunits prevents the changes
in stoichiometry of these two enzymes that should take place early in response to sepsis to compensate for the decrease in ATP and the increase in ROS generation. These
changes in stoichiometry are an instantaneous response to ETC failure because biogenesis
compensation takes much longer to occur in the recovery phase of sepsis (Figure 3C).
As a consequence, therapies combining the acceleration of mitochondrial biogenesis and
improvement of the stoichiometry of both enzymes should be considered in therapies to
restore liver mitochondrial function during sepsis.
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